Gavo-cel shows promising phase I/II results in patients with mesothelin-overexpressing solid tumors May 11, 2021 No Comments
Key interim analysis findings from phase Ia/Ib monotherapy study of CUE-101 in HNSCC May 11, 2021 No Comments
Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab May 11, 2021 No Comments
Cantargia plans to study CAN-04 with carboplatin/gemcitabine in advanced TNBC May 10, 2021 No Comments
Telix cleared in Australia to begin phase III study of TLX-591 for metastatic CRPC May 10, 2021 No Comments
RSS